108 search results for: patient burden

expert video

The Multidimensional Impact of Atopic Dermatitis on Children and Their Caregivers

1 min

Dermatology

Discover the multidimensional impact of pediatric atopic dermatitis on children and caregivers – a soundbite from the Expert Lounge Canada 2022.

expert video

Why did the definition of control in CRSwNP change between EPOS 2020 and EPOS/EUFOREA 2024?

5 min

Rhinology

Prof. Hellings and Prof. Corso discuss the significance and rationale behind the new definition of CRSwNP.

expert video

How Should We Define and Classify Prurigo Nodularis?

13 min

Dermatology

Dr. Sarina Elmariah explains how to recognize and classify PN, using clinical examples and comparisons with related conditions. She then discusses PN assessment in clinical studies and practice, and the unmet needs in disease understanding and diagnosis.

videoanimation

Type 2 Inflammation and Airway Remodeling Drive Lung Function Decline

4 min

Pulmonology

Explore the impact of type 2 inflammation and airway remodeling on lung function decline in asthma.

expert video

Comorbidities and Clinical Management in CSU

4 min

Dermatology

In their interview Drs. Maurer and Ensina highlight the understanding of comorbidities in CSU is important in clinical management.

expert video

ERS 2023 | How Achievable Is Clinical Remission on Biologic Therapy?

12 min

Pulmonology

Dr. Francesca Puggioni presents the latest clinical data on achieving on-treatment remission with biologics.

expert video

Cumulative Exposure to Corticosteroids in Type 2 Inflammatory Diseases

1 min

Type 2 Inflammation

Dr. Evan Dellon highlights potential risks with cumulative use of steroids for treatment of various coexisting type 2 inflammatory diseases.

expert video

ERS 2023 | Advancing Asthma Management Beyond Control

12 min

Pulmonology

Prof. Ian Pavord discusses the current proposed framework for clinical remission in severe asthma.

expert video

ERS 2023 | Assessing Disease Activity to Better Define On-Treatment Clinical Remission in Pediatric Severe Asthma

10 min

Pulmonology

Join pediatric asthma experts Prof. Giorgio Piacentini and Dr. Sharon Dell for an educational program on the topic of remission in pediatric asthma.

expert video

Evaluating the Responses to Biologic Therapies in Children With Atopic Dermatitis

2 min

Dermatology

Dr. Amy Paller shares her opinion on practical considerations for evaluating response during treatment with biologics in children with atopic dermatitis.

expert video

New Horizons in Children With Atopic Dermatitis: Emerging Evidence in Disease Management

29 min

Dermatology

Review the evolving therapeutic landscape for children with AD, considering clinically relevant data supporting the use of advanced systemic therapies.

expert video

ERS 2023 | On-Therapy Remission in Pediatric Asthma: Where Are We Today?

39 min

Pulmonology

Join pediatric asthma experts Prof. Giorgio Piacentini and Dr. Sharon Dell for an educational program on the topic of remission in pediatric asthma.

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: PolandChange country/region